Skip to main content
LFWD logo

LFWD · Lifeward Ltd.

Track LFWD — free
$7.10 -0.16 (-2.20%) At close · Sep 3
Market Cap
$20.56M
Shares
2.83M

LFWD metrics

58 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.10
Market cap
$20.56M

Price action

19 metrics
Price change (1W)
-3.1%
Price change (30D)
+0.7%
Price change (3M)
-0.3%
Price change (6M)
+21.2%
Price change (YTD)
Price change (1Y)
Trailing year
Price change (5Y)
52-week high
52-week low
Change from 52-week high
Change from 52-week low
Annualized volatility
64.7%
Beta
0.8
RSI (14D)
46.0
Price vs SMA 50
-3.4%
Price vs SMA 200
Avg volume (3M)
9,838
Relative volume
0.4
Average dollar volume
$76,874

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
2.83M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.9×
reciprocal yield 107.0%
P / book
1.7
reciprocal yield 59.9%
FCF yield
-83.8%
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-151.2%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
10.2×
reciprocal yield 9.8%
EV / revenue historical average (5Y)
10.2×
reciprocal yield 9.8%
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-05-15

Profitability

9 metrics
Gross margin
36.0%
Operating margin
-104.2%
Trailing 12 months
Net margin
-141.3%
Gross profit (TTM)
$7.85M
Operating profit (TTM)
−$22.75M
Net income (TTM)
−$30.83M
Trailing 12 months
Diluted EPS (TTM)
$-15.44
FCF margin
-78.3%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$307.52

Growth

11 metrics
Revenue growth YoY
+15.7%
Year over year
Net income growth YoY
Revenue (TTM)
$21.82M
Trailing 12 months
EPS growth YoY
Shares change YoY
+198.9%
Year over year · more shares
Revenue CAGR (3Y)
+58.7%
Revenue CAGR (5Y)
+38.1%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-252.4%
Return on assets
-88.1%
Debt / equity
Current ratio
2.3
EBITDA (TTM)
Free cash flow (TTM)
−$17.10M
Quick ratio
1.8
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$9.45M
Total assets
$35.00M
Total debt
$3.43M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.08M
Capital expenditures (TTM)
$19,000
R&D (TTM)
$9.16M
SG&A (TTM)
Stock compensation (TTM)
$780,000
R&D / revenue
42.0%
Stock compensation / revenue
3.6%

Ownership (13F)

3 metrics
13F filers
9
13F filer change QoQ
+1
Institutional ownership
1.1%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 17.8 days to cover
Days to cover
17.8d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1607962 CUSIP M8216Q309 13F (30d) 8 filings 8 filers Visit website Investor relations